Table 1.

Patient clinical outcomes hemotoxic mast cell stain

	N (% of total 36 patients)
Stage
IIIA	1 (3%)
IIIB	5 (14%)
IIIC	25 (69%)
IV	5 (14%)
Recurred
Yes	32 (89%)
No	4 (11%)
Overall Survival Status
Living	11 (30%)
Deceased	23 (64%)
Lost to Follow up	1 (3%)
Deceased not from HGSOC	1 (3%)
	Median [Range]
Age at Diagnosis	63 [46–79]
PFS (months)	16 [6–51]
OS (months)	40 [12–83]